Kamada vs Maravai LifeSciences
KMDA and MRVI side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How KMDA and MRVI compare
Kamada grew revenue faster over the last twelve months (13.2% versus −5.0% for Maravai LifeSciences).
Maravai LifeSciences scores higher on the StockData Score (7 against 5 for Kamada), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | KMDA | MRVI |
|---|---|---|
| Size and price | ||
| Market cap | – | $1.9B |
| Share price | $8.11 | $7.40 |
| Change, 1 year | 14.5% | 128% |
| Change, 5 years | 28.5% | −82.2% |
| Beta (5Y) | 0.84 | 0.29 |
| Employees | 393 | 435 |
| StockData Score | ||
| Total score | 5 | 7 (better) |
| Valuation score | 0 | 0 |
| Growth score | 2 | 2 |
| Performance score | 0 | 2 (better) |
| Health score | 3 | 3 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | – | 9.2× |
| P/B | – | 9.4× |
| FCF yield | – | −1.9% |
| Fair value | – | $2.74 |
| Margin of safety | – | −170% |
| Growth | ||
| Revenue growth (TTM) | 13.2% (better) | −5.0% |
| Revenue growth, 5Y average | 6.3% (better) | −8.1% |
| EPS growth, 5Y average | −1.6% | – |
| Profitability | ||
| Gross margin | 40.8% (better) | 34.9% |
| Operating margin | 14.5% (better) | −56.1% |
| Net margin | – | −37.1% |
| FCF margin | – | −17.2% |
| Return on equity | – | −32.9% |
| Return on invested capital | – | −32.4% |
| Financial health | ||
| Debt / equity | – | 0.72 |
| Net debt / EBITDA | −0.54 | – |
| Interest coverage | 26.8× (better) | −4.9× |
| Current ratio | 4.06 (better) | 4.05 |
| Altman Z-score | – | 4.57 |
| Piotroski F-score | – | 2 |
| Dividends and buybacks | ||
| Shareholder yield | – | 0.00% |
| Ownership | ||
| Held by institutions | 8.6% | 55.5% |
| Held by insiders | 45.3% | 3.6% |
| Insider net buying, 12 months | −$1.7M | $115K (better) |
| Short interest, % of float | 0.53% | 5.6% |
Go deeper
- KMDA stock overview
- KMDA income statement
- KMDA valuation and score
- MRVI stock overview
- MRVI income statement
- MRVI valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.